On June 12, 2025, Sensei Biotherapeutics, Inc. announced a 1-for-20 reverse stock split and reduced the total authorized shares from 250 million to 12.5 million, effective June 16, 2025. This change was approved by shareholders on May 21, 2025, and will adjust all existing stock options and equity compensation plans accordingly.